When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Macroblepharon is an anatomical malformation in dogs where the palpebral fissure, i.e., the distance between the upper and lower eyelids, is excessively large. This anomaly can lead to various eye problems that impair the dog’s quality of life.
Das Wichtigste auf einen Blick
Macroblepharon is a genetically determined malformation of the eyelids in dogs, in which the palpebral fissure is too wide. This anomaly often occurs in breeds such as Cocker Spaniels, Basset Hounds, and Bloodhounds, which are known for their large, open eyes. The genetic components are not yet fully understood, but it is suspected that multiple genes are involved. In addition to genetic factors, environmental factors such as injuries or chronic irritation can worsen Symptoms. Common Symptoms include visible sclera, Conjunctival hyperemia, keratitis, and Pain. Rare Symptoms include corneal drying and corneal ulcers. The Diagnosis is made through a clinical examination in which the size of the palpebral fissure is measured, as well as through special tests such as slit-lamp biomicroscopy, which can be used to assess the severity of the condition. Treatment ranges from eye drops in mild cases to surgical interventions such as blepharoplasty in more severe cases. Careful follow-up care is crucial for successful healing. The Prognosis depends on the severity of the malformation and timely treatment. Prevention consists of responsible breeding practices and regular eye examinations in at-risk breeds. Research focuses on genetic factors, surgical techniques, and environmental factors to improve the quality of life of affected dogs.
Ursachen
A dog’s eye is a complex system protected by the correct structure and function of the eyelids. These eyelids are crucial for protecting the eyeball from external influences, for the even distribution of tear fluid, and for removing small particles from the eye surface.
Macroblepharon occurs when the embryonic development of the eyelids is disrupted. This leads to excessive exposure of the eye surface. This malformation is often genetically determined and occurs more frequently in certain breeds known for their large, open eyes, such as Cocker Spaniels, Basset Hounds, and Bloodhounds.
The genetic components of this malformation are not yet fully understood, but it is suspected to involve polygenic inheritance, where multiple genes play a role. These genetic changes lead to an excessive development of the palpebral fissure, which in turn can cause a range of other eye problems.
In addition to genetic predisposition, environmental factors such as injuries or chronic eye irritations can worsen symptoms or increase the risk of complications. These factors can further weaken the eye’s natural protective barrier, leading to recurrent eye infections and other problems.
Symptoms
The symptoms of macroblepharon are often clearly recognizable and can be detected at an early age. Dogs with this malformation often show excessive tear production because the eyes try to keep the highly exposed surface moist.
Another common symptom is conjunctivitis, an inflammatory condition of the conjunctiva of the eye. This inflammation is promoted by constant exposure to dust and other irritants. Affected dogs often show Conjunctival hyperemia, Swelling, and eye discharge.
Due to insufficient coverage by the eyelids, dogs are also prone to corneal ulcers caused by constant contact with foreign bodies or drying out. Such ulcers can be painful and, if left untreated, can lead to serious complications.
Diagnose
The diagnosis of macroblepharon is usually made through a thorough clinical examination of the eye by a veterinarian. The veterinarian will measure the size of the palpebral fissure and look for signs of secondary eye diseases.
To assess the severity of the condition, the veterinarian may perform special tests, such as slit-lamp biomicroscopy. This examination method allows a detailed view of the anterior eye structures and helps to better understand the extent of the damage.
In some cases, a Schirmer tear test may also be required to measure the dog’s tear production. A reduced tear flow may indicate an additional disorder of the lacrimal glands caused by the malposition of the eyelids.
Therapie
The treatment of macroblepharon aims to alleviate the symptoms and protect the dog’s eyes. In mild cases, eye drops or ointments may be prescribed to keep the eyes moist and reduce irritation.
In more severe cases, surgical intervention may be necessary. Blepharoplasty is a surgical procedure that aims to reduce the size of the palpebral fissure and correct the position of the eyelids. This surgery can significantly reduce the risk of corneal ulcers and other complications.
After surgery, careful follow-up care is required to ensure the eyes heal properly. The veterinarian will usually schedule regular check-ups to monitor healing and prevent complications.
Prognose und Nachsorge
The prognosis for dogs with Macroblepharon largely depends on the severity of the malformation and timely treatment. With early diagnosis and appropriate treatment, the prognosis is generally good, and affected dogs can lead a normal, symptom-free life.
Without treatment, however, chronic eye problems can occur and lead to permanent damage. This can significantly impair the dog’s quality of life and may require lifelong care as well as medical interventions.
Prävention
The best prevention against macroblepharon is to promote responsible breeding practices. Breeders should ensure they do not breed dogs with genetic predispositions for this malformation in order to minimize the risk for future generations.
Regular eye examinations in dogs from at-risk breeds can also help detect the disease early and take appropriate measures. Early interventional treatment can help avoid more serious complications and improve the dog’s quality of life.
Ausblick auf aktuelle Forschung
Research into macroblepharon, an anatomical anomaly in dogs, focuses on genetic causes, predisposing factors, and therapeutic advances. This condition is characterized by an excessively large palpebral fissure, which can lead to various health problems, including eye irritation, dryness, or even corneal damage. Current genetic studies aim to identify specific genes associated with the development of macroblepharon. This could enable breeders to reduce the prevalence of this condition in certain dog breeds.
Another research focus is on improving surgical techniques to correct macroblepharon. Surgical treatment is often required to reduce the palpebral fissure and minimize the risk of eye injuries. New minimally invasive procedures are being developed to shorten recovery time and reduce the risk of postoperative complications. Advances in surgery are supported by state-of-the-art imaging techniques that enable more precise planning and execution of interventions.
In addition, studies are looking at the role of environmental factors and their influence on the severity of symptoms in dogs with macroblepharon. Researchers are investigating how factors such as allergens, environmental pollution, and diet can affect the well-being of affected dogs. The aim is to develop management strategies that reduce the occurrence of complications.
In veterinary ophthalmology, new drug treatments are also being researched to relieve the symptoms of macroblepharon. These include the development of eye drops specifically tailored to the needs of dogs with this condition, as well as anti-inflammatory medications that can reduce the risk of infections and Inflammatory conditions.
Integrating data from genetic, clinical, and environmental studies helps develop a more comprehensive understanding of macroblepharon. These interdisciplinary approaches could contribute in the future to the development of personalized treatment plans for affected dogs and significantly improve their quality of life.
Frequently Asked Questions (FAQs)
1. What is macroblepharon in dogs?
2. Which dog breeds are most commonly affected by macroblepharon?
3. What symptoms occur in dogs with macroblepharon?
4. How is macroblepharon diagnosed?
5. What treatment options are available for dogs with macroblepharon?
6. Can macroblepharon be prevented?
7. How does macroblepharon affect a dog's quality of life?
8. Are there home remedies for treating macroblepharon?
9. Is surgery to correct macroblepharon risky?
10. How often are follow-up check-ups required after surgery?
Literatur
- Werner-Tutschku, M., & Nell, B. (2025). Lateral tarsorrhaphy and fixation on the orbital ligament to correct macroblepharon in dogs: 77 palpebral fissures. Veterinary Ophthalmology, 28(2), 448–456. https://doi.org/10.1111/vop.13316
- Costa, J., Steinmetz, A., & Delgado, E. (2021). Clinical signs of brachycephalic ocular syndrome in 93 dogs. Irish Veterinary Journal, 74(1), Article 3. https://doi.org/10.1186/s13620-021-00183-5
- Sebbag, L., & Sanchez, R. F. (2023). The pandemic of ocular surface disease in brachycephalic dogs: The brachycephalic ocular syndrome. Veterinary Ophthalmology, 26(Suppl. 1), 31–46. https://doi.org/10.1111/vop.13054
- O’Neill, D. G., Mustikka, M. P., Brodbelt, D. C., Church, D. B., & Vaattovaara, V. (2025). Conformational eyelid disorders in dogs under primary veterinary care in the UK: Epidemiology and clinical management. PLoS ONE, 20(6), Article e0326526. https://doi.org/10.1371/journal.pone.0326526
- Andrews, A. L. M. M., Youngman, K. L., Packer, R. M. A., O’Neill, D. G., & Kafarnik, C. (2023). A review of clinical outcomes, owner understanding and satisfaction following medial canthoplasty in brachycephalic dogs in a UK referral setting (2016–2021). Animals, 13(12), Article 2032. https://doi.org/10.3390/ani13122032
- Costa, A. R., Ribeiro, T. A., Silva, D. M. C., Júnior, J. R. da S., Lima, T. B., Gil da Costa, R. M., Faustino-Rocha, A. I., Oliveira, P. A., & Abreu-Silva, A. L. (2025). Effects of canthoplasty in preventing secondary ocular surface lesions in brachycephalic dogs. Veterinary Sciences, 12(9), Article 889. https://doi.org/10.3390/vetsci12090889